Department of General Surgery, University General Hospital of Heraklion, Heraklion, Crete 71110, Greece.
Laboratory of Biostatistics, Division of Social Medicine, School of Medicine, University of Crete, Heraklion, Crete 71110, Greece.
Hepatobiliary Pancreat Dis Int. 2022 Dec;21(6):527-537. doi: 10.1016/j.hbpd.2022.04.006. Epub 2022 Apr 25.
In the past decades, the perioperative management of patients undergoing pancreaticoduodenectomy (PD) has undergone major changes worldwide. This review aimed to systematically determine the burden of complications of PD performed in the last 10 years.
A systematic review was conducted in PubMed for randomized controlled trials and observational studies reporting postoperative complications in at least 100 PDs from January 2010 to April 2020. Risk of bias was assessed using the Cochrane RoB2 tool for randomized studies and the methodological index for non-randomized studies (MINORS). Pooled complication rates were estimated using random-effects meta-analysis. Heterogeneity was investigated by subgroup analysis and meta-regression.
A total of 20 randomized and 49 observational studies reporting 63 229 PDs were reviewed. Mean MINORS score showed a high risk of bias in non-randomized studies, while one quarter of the randomized studies were assessed to have high risk of bias. Pooled incidences of 30-day mortality, overall complications and serious complications were 1.7% (95% CI: 0.9%-2.9%; I = 95.4%), 54.7% (95% CI: 46.4%-62.8%; I = 99.4%) and 25.5% (95% CI: 21.8%-29.4%; I= 92.9%), respectively. Clinically-relevant postoperative pancreatic fistula risk was 14.3% (95% CI: 12.4%-16.3%; I = 92.0%) and mean length of stay was 14.8 days (95% CI: 13.6-16.1; I = 99.3%). Meta-regression partially attributed the observed heterogeneity to the country of origin of the study, the study design and the American Society of Anesthesiologists class.
Pooled complication rates estimated in this study may be used to counsel patients scheduled to undergo a PD and to set benchmarks against which centers can audit their practice. However, cautious interpretation is necessary due to substantial heterogeneity.
在过去的几十年中,全世界范围内接受胰十二指肠切除术(PD)的患者围手术期管理发生了重大变化。本综述旨在系统地确定过去 10 年中 PD 术后并发症的负担。
在 PubMed 上进行了系统评价,检索了 2010 年 1 月至 2020 年 4 月期间至少报告了 100 例 PD 术后并发症的随机对照试验和观察性研究。使用 Cochrane RoB2 工具评估随机研究的偏倚风险和非随机研究的方法学指数(MINORS)评估观察性研究的偏倚风险。使用随机效应荟萃分析估计汇总并发症发生率。通过亚组分析和荟萃回归来研究异质性。
共纳入了 20 项随机研究和 49 项观察性研究,共报告了 63229 例 PD。平均 MINORS 评分显示非随机研究存在高偏倚风险,而四分之一的随机研究被评估为存在高偏倚风险。30 天死亡率、总并发症和严重并发症的汇总发生率分别为 1.7%(95% CI:0.9%-2.9%;I=95.4%)、54.7%(95% CI:46.4%-62.8%;I=99.4%)和 25.5%(95% CI:21.8%-29.4%;I=92.9%)。具有临床意义的术后胰瘘风险为 14.3%(95% CI:12.4%-16.3%;I=92.0%),平均住院时间为 14.8 天(95% CI:13.6-16.1;I=99.3%)。荟萃回归部分将观察到的异质性归因于研究的来源国、研究设计和美国麻醉医师协会分级。
本研究中估计的汇总并发症发生率可用于向计划接受 PD 的患者提供咨询,并为中心评估其实践提供基准。然而,由于存在很大的异质性,因此需要谨慎解释。